Show simple item record

dc.contributor.authorCagney, DN
dc.contributor.authorArmstrong, JG
dc.date.accessioned2017-02-17T16:58:00Z
dc.date.available2017-02-17T16:58:00Z
dc.date.issued2017-01
dc.identifier.urihttp://hdl.handle.net/10147/621072
dc.description.abstractCancer incidence across Europe is projected to rise rapidly over the next decade. This rising cancer incidence is mirrored by increasing use of and indications for stereotactic radiation. This paper seeks to summarize the exponential increase in indications for stereotactic radiotherapy as well as the evolving economic advantages of stereotactic radiosurgery and stereotactic body radiotherapy
dc.language.isoenen
dc.publisherIrish Medical Journalen
dc.subjectCANCERen
dc.subjectRADIOTHERAPYen
dc.titleStereotactic Radiosurgery (SRS) / Stereotactic body radiotherapy (SBRT): Benefit to Irish patients and Irish Healthcare Economyen
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
html.description.abstractCancer incidence across Europe is projected to rise rapidly over the next decade. This rising cancer incidence is mirrored by increasing use of and indications for stereotactic radiation. This paper seeks to summarize the exponential increase in indications for stereotactic radiotherapy as well as the evolving economic advantages of stereotactic radiosurgery and stereotactic body radiotherapy


Files in this item

Thumbnail
Name:
ART5.html
Size:
42.39Kb
Format:
HTML
Description:
Main Article

This item appears in the following Collection(s)

Show simple item record